Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04243889 · ClinicalTrials.gov registry record · NA
Fetoscopic NEOX Cord 1K® Spina Bifida Repair
A NA study of Spina Bifida and Myelomeningocele, sponsored by The University of Texas Health Science Center, Houston.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04243889 is a NA study of Spina Bifida and Myelomeningocele that is active but no longer recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 50 participants, roughly in line with the 50-participant average among 16 other Spina Bifida trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT04243889, a NA study of Spina Bifida and Myelomeningocele, is active but no longer recruiting, sponsored by The University of Texas Health Science Center, Houston.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
To fetoscopically use cryopreserved human umbilical cord allografts, named NEOX Cord 1K®, as a spinal cord cover of spina bifida defects. This procedure will be performed to create a watertight seal covering over the spinal cord in order to decrease the incidence rates of postnatal morbidities. For larger skin defects, NEOX Cord 1K® may be used as a skin cover.
Conditions Studied
Interventions
- DEVICE NEOX Cord 1K
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-08-28 |
| Est. Completion | 2029-03-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04243889
The ClinicalTrials.gov registry entry for NCT04243889 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 50-participant average among 16 other Spina Bifida trials with a reported enrollment target. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Spina Bifida appearing as the primary indexed condition, and to 1 intervention - of which NEOX Cord 1K is the first listed.
NCT04243889 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04243889 about?
NCT04243889 is a clinical study titled "Fetoscopic NEOX Cord 1K® Spina Bifida Repair". To fetoscopically use cryopreserved human umbilical cord allografts, named NEOX Cord 1K®, as a spinal cord cover of spina bifida defects. This procedure will be performed to create a watertight seal covering over the spinal cord in order to decrease the incidence rates of postnatal morbidities. For ...
What is the current status of trial NCT04243889?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2020-08-28. Estimated completion is 2029-03-12.
What conditions does trial NCT04243889 study?
This clinical trial studies the following conditions: Spina Bifida, Myelomeningocele, Myeloschisis.
What interventions are being tested in trial NCT04243889?
The interventions under investigation include: NEOX Cord 1K (DEVICE).
Who is sponsoring clinical trial NCT04243889?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04243889 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spina Bifida
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder
RECRUITING · NA
-
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
RECRUITING · NA
-
Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects
RECRUITING · NA
-
Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
RECRUITING · NA
-
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.